Because the outcome after major bowel resection in the neonatal period depends primarily on the time needed for adaptation of the bowel,lO it is of utmost importance to achieve enteral autonomy as soon as possible. Depending on the composition of the luminal content, mucosal growth can be enhanced."-l5
Of the individual dietary components, it has been suggested that long-chain triglycerides (LCT) may be especially potent promoters of small intestinal mucosal cell proliferation. 14,16-18 However, because fat malabsorption is common in these patients,19,20 supplying medium-chain triglycerides (MCT) instead of LCT is a standard practice. The reason for this is that MCT are hydrolysed more rapidly by pancreatic lipase than are LCT21 and are transported principally by the portal vein to the liver for oxidation rather than through the intestinal lymphatic vessels, which are used by LCT.22 Because little is known about the adaptation that occurs with time in MCT-and LCT-derived fatty acid (FA) malabsorption and about whether this malabsorption/adaptation is chain-length dependent, we conducted a prospective study that evaluates FA absorption and excretion in neonates with SBS and neonates who underwent minor small bowel resection. The patients were divided into two groups. Eight had SBS (SBS group), defined as a loss of more than 50% of the original small bowel as related to gestational age.23 The mean remaining small bowel length related to gestational age in this group was 34% (range, 24% to 42%). Thirteen patients had only minor small bowel resections (non-SBS group), and served as controls. Their mean remaining small bowel length related to gestational age averaged 95% (range, 70% to 100%).
MATERIALS AND METHODS

Patients
In the SBS group (n = 8), five patients had an ileostomy; in the non-S&IS group (n = 13) nine patients had an ileostomy and one had a colostomy.
As reported earlier, 24 the intestinal continuity in these groups of patients was reestablished after an average of approximately 100 days after the initial operation. Growth was recorded regularly. Patient data are summarized in Table 1. FA Intake, Excretion, and Analysis
The patients participated in a prospective evaluation of nutritional intake of FA and faecal excretion of FA. The protocol was begun after 2 weeks of recovery and stabilization of the patient and after informed consent was obtained from the parents or caretakers. During a 72.hour period, enterostomy fluid or faeces were collected for analysis at week 2 and 1, 2, and 3 months postoperatively, and subsequently one-time 24-hour faeces were collected at 4,6, and 12 months postoperatively.
FA intake was calculated from the amount of food intake of a specific formula and the FA content of that formula.
FA excretion was calculated from enterostomy fluid or faecal collections and from the FA concentrations. For FA analysis, the total stool sample was homogenized and the volume determined.
Then, a representative sample was taken, which was analyzed by use of gas chromatography. 
RESULTS
Patient characteristics are summarized in Table 1 . The SBS and non-SBS groups are comparable with the exception of the mean remaining bowel length, which was 34% (24% to 42%) and 95% (70% to 100%) respectively.
In Table 2 , the fractional faecal FA excretion in SBS and non-SBS patients is shown. Data are presented as mean 2 SEM. The results show that total FA fractional excretion at 2 weeks and 1, 2, 3 and 4 months postsurgery was 51% ? 37%, 33% & 24%, 51% t 65%, 53% & 27%, and 7% _t 2% in SBS patients and 12% ? 8%, 24% +-lo%, 9% -+ 3%, 8% 2 3%, and 17% ? 14% in non-SBS controls, respectively. Statistical analysis (ANOVA) for the period between 2 weeks and 3 months postsurgery showed a significant difference between the curves (Fig 1) .
With respect to the fractional faecal FA excretion of the individual chain lengths, the following results were obtained. faecal excretion did not differ significantly for the two patient groups, and ranged, at the observed time points, between 1% ? 1% and 24% f 14%, with a few exceptionally high values. In neither the Cl0 nor the Cl2 group of FA was there a significant difference between the curves (ANOVA analysis for the period between 2 weeks and 3 months as well as for all other time ranges). For the Cl0 FA, this is depicted in Fig  2. For the C14, C16, and Cl8 FA, the fractional faecal excretion ranged from 40% to more than 80% in the SBS group, and was significantly higher (ANOVA analysis In the present study we found that FA absorption (as assessed by the measurement of fractional FA excretion in stools) in neonates with SBS is. dependent on FA chain length and on the time between evaluation and initial small bowel resection. The shorter chain lengths, especially Cl0 and C12, are absorbed almost completely from the time enteral nutrition is begun. The longer chain lengths are malabsorped for at least 12 weeks after surgery. From our data it appears that there is a separation point in ing LCT and MCT was evaluated and it was shown that MCT are more rapidly hydrolysed and absorbed in the intestinal lumen than are LCT.22 The proximal small bowel being the preferred side of MCT absorption and the mid and distal small bowel being the preferred side of LCT absorption might explain why there is a difference in fractional faecal FA excretion between the SBS and non-SBS groups.
Although the advantage of MCT from the standpoint of rate of absorption in SBS has been well documented,21,27 little is known about the effect of the remaining colon on FA (mal)absorption and about the effect of LCTversus MCT on mucosal adaptation.
In the present study there appeared to be a rapid decrease in the malabsorption of Cl4 and longer FA chains, and thus enhanced adaptation between 3 and 4 months postsurgery. This coincides with the closure of enterostomies around this time.24 The sudden amelioration in the absorption of the longer FA after 3 months might be attributable true adaptation in the small bowel remnant in the SBS group. Alternatively, this might be related to the inclusion of the colon in the intestinal stream after closure of enterostomies, with or without a terminal ileal segment and the ileocoecal valve. Regardless of this adaptation or its explanation, the data provide evidence that it might be better to give MCTs instead of LCTs during the first 3 months after resection.
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Morin et all4 reported that, in rats, morphological mucosal hyperplasia (as determined by measurement of mucosal protein and DNA content) was greater after LCT feedings than after to MCT feedings. Vanderhoof et all3 confirmed these results in rats and added the observation that mucosal function improved after the use of LCT feedings, as demonstrated by enhanced leucine uptake in the distal small bowel and enhanced sucrase activity in the proximal small bowel in the: animals subjected to small bowel resection. To clarify the relative enterotrophic actions of different triglycerides, Jenkins and Thompson28 gave rats five different oils in mixed diets and compared the effelcts on the overall mass of the small intestine and on the distribution of mass along the small intestine. Subsequently, the enterotrophic 'effects of bolus doses of LCT and MCT were compared. They found that LCT and MCT differed in their regional effects on cell proliferation; all four LCTrich diets increased mucosal mass and cell proliferation maximally in the mid small intestine, whereas MCT diets had thle greatest effect proximally. When the LCT and MCT diets were given as boluses, the differences disappeared. The authors suggested that the enterotrophic effect of bolus MCT is the result of accelerated transit causing the release in the distal small bowel of am enterotrophic peptide that enhanced the overall trophic effect to the small bowel. It is noteworthy that the infusion of MCT directly into the human ileum causes a release of enteroglucagon,29 which has been proposed as an enterotrophic hormone.30 In summary, it is possible that LCT-rich diets have a positive effect 'on adaptation after small bowel resection. However, the issue is whether this positive LCT effect outweighs the physiological advantages of MCT. From our clinical data and the results of animal studies, it remains unclear which form of triglycerides (MCT or LCT) should be used in SBS patients. One animal study has addressed this question, comparing the relative effects of diet mixtures containing either 50% MCT/SO% LCT or 100% LCT.31 It was shown that the diet that contained 50% MCT/SO% LCT led to a higher increase in the mucosal mass and protein content. It was found that the mixed diet determined the most appropriate lipid content and composition in the brush-border membrane.32 There were no deleterious effects of the mixed diet on the activities of sucrase, lactase, or aminopeptidase.33
On the basis of our data and the literature cited, it is our opinion that the enteral diet of neonates with SBS should contain a mixture of MCT and LCT, to combine the physiological advantages of MCT with
